Sustained VEGF delivery via PLGA nanoparticles promotes vascular growth.
暂无分享,去创建一个
Craig L Duvall | Robert E Guldberg | Ravi V Bellamkonda | Young-tae Kim | R. Bellamkonda | C. Duvall | D. Weiss | R. Guldberg | Divya Gupta | A. Lin | Daiana Weiss | Justin S Golub | Divya Gupta | Justin S. Golub | Angela S Lin | Young-tae Kim | W Robert Taylor | W. Robert Taylor | Daiana Weiss
[1] S. Schwendeman,et al. Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide) , 2000, Nature Biotechnology.
[2] V. Labhasetwar,et al. Characterization of nanoparticle uptake by endothelial cells. , 2002, International journal of pharmaceutics.
[3] Brian H Annex,et al. The VIVA Trial Vascular Endothelial Growth Factor in Ischemia for Vascular Angiogenesis , 2003 .
[4] J. Isner,et al. Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. , 1994, Circulation.
[5] C Vigneron,et al. Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[6] L. Devy,et al. Mouse Aortic Ring Assay: A New Approach of the Molecular Genetics of Angiogenesis , 2002, Biological Procedures Online.
[7] D. Crommelin,et al. Controlled release of bioactive agents from lactide/glycolide polymers , 1990 .
[8] J. Isner,et al. Mouse model of angiogenesis. , 1998, The American journal of pathology.
[9] E. Brogi,et al. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. , 1994, The Journal of clinical investigation.
[10] R. A. Jain,et al. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. , 2000, Biomaterials.
[11] H. Gundersen,et al. Quantification of connectivity in cancellous bone, with special emphasis on 3-D reconstructions. , 1993, Bone.
[12] G. Jia,et al. Formulation and characterization of poly (d,l‐lactide‐co‐glycolide) nanoparticle containing vascular endothelial growth factor for gene delivery , 2006, Journal of clinical pharmacy and therapeutics.
[13] Chad Johnson,et al. The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis. , 2004, Biomaterials.
[14] Armin Helisch,et al. Contribution of arteriogenesis and angiogenesis to postocclusive hindlimb perfusion in mice. , 2002, Journal of molecular and cellular cardiology.
[15] Craig L Duvall,et al. The Role of Osteopontin in Recovery from Hind Limb Ischemia , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[16] D. Nolte,et al. Restoration of blood flow and evaluation of corresponding angiogenic events by scanning electron microscopy after a single dose of VEGF in a model of peripheral vascular disease , 2004, Angiogenesis.
[17] Jayanth Panyam,et al. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. , 2003, Advanced drug delivery reviews.
[18] E. Manseau,et al. Vascular Permeability Factor/Vascular Endothelial Growth Factor Induces Lymphangiogenesis as well as Angiogenesis , 2002, The Journal of experimental medicine.
[19] F. Sellke,et al. Therapeutic angiogenesis for coronary artery disease , 2002, Current treatment options in cardiovascular medicine.
[20] W. R. Taylor,et al. Quantitative microcomputed tomography analysis of collateral vessel development after ischemic injury. , 2004, American journal of physiology. Heart and circulatory physiology.